期刊文献+

血清adropin蛋白水平与冠心病的相关性 被引量:13

Correlation of serum adropin level with coronary artery disease
原文传递
导出
摘要 目的 探讨血清adropin蛋白水平与冠心病的相关性.方法 选择2011年1月至2012年7月因胸痛、胸闷首次于苏州大学附属第二医院就诊的患者356例,根据冠状动脉造影结果分为冠心病组(264例)与对照组(92例).测定血清adropin、高敏C反应蛋白、空腹血糖、空腹血浆胰岛素浓度.冠心病组患者计算SYNTAX得分.结果 冠心病组患者的血清adropin浓度明显低于对照组[(56±15)比(83±10) ng/L,P<0.01].SYNTAX低分组、中分组、高分组患者的血清adropin浓度分别为(60±22)、(56±12)、(54±10) ng/L,3组间差异无统计学意义(P=0.116).多因素Logistic回归分析显示低血清adropin水平是冠心病发病的独立危险因素(OR=0.849,95% CI:0.817~0.882,P<0.01).结论 低血清adropin水平与冠心病具有相关性,adropin可能在冠心病的发病中起保护作用. Objective To explore the correlation of serum adropin level with coronary artery disease (CAD).Methods According to coronary angiography,356 consecutive patients with chest complaints from January 2011 to July 2012 were divided into 2 groups of CAD (n =264,with CAD) and control (n =92,without CAD).The serum adropin level and other CAD related metabolic parameters were measured and SYNTAX score was calculated.Results Serum adropin level was significantly lower in group CAD than that in control group ((56 ± 15) vs (83 ± 10) ng/L,P < 0.01).Serum adropin levels in high,mild,low SYNTAX score group were (60 ± 22),(56 ± 12),(54 ± 10) ng/L respectively,and there was no significant difference among 3 groups(P =0.116).Multivariate regression analysis revealed that adropin was an independent risk factor for CAD (OR =0.849,95% CI:0.817-0.882,P <0.01).Conclusions Lower serum adropin level is significantly associated with CAD.Thus it indicates a possible role of adropin in the prevention of CAD.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第16期1255-1257,共3页 National Medical Journal of China
关键词 冠状动脉疾病 危险因素 Adropin Coronary disease Risk factors Adropin
  • 相关文献

参考文献10

  • 1Tenenbaum A, Adler Y, Boyko V, et al. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease [ J ]. Am Heart J, 2007,153:559-565.
  • 2乔岩,聂绍平,杜昕,刘小慧,张崟,康俊萍,吕强,贾长琪,马长生.糖尿病对冠心病多支血管病变患者经皮冠状动脉介入治疗术后疗效的影响[J].中华医学杂志,2013,93(22):1700-1704. 被引量:12
  • 3Kumar KG,Trevaskis JL,Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronntrient intake with energy homeostasis and lipid metabolism [ J ]. Cell Metab, 2008, 8:468-481.
  • 4Lovren F, Pan Y, Quan A, et al. Adropin is a novel regulator of endothelial function [ J ]. Circulation, 2010,122 ( 11 Suppl ) : S 185 - S192.
  • 5Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [J]. Diabetologia, 1985,28:412-419.
  • 6Celik A, Balin M, Kobat MA, et al. Deficiency of a new protein associated with cardiac syndrome X; called adropin [J]. Cardiovasc Ther,2013,31 : 174-178.
  • 7Topuz M, Celik A, Aslantas T, et al. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus [ J ]. J Investig Med, 2013,61 : 1161 - 1164.
  • 8Wu L, Fang J, Chen L, et al. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients [ J ]. Clin Chem Lab Med,2013,9 : 1-8.
  • 9赵良平,徐卫亭,陈建昌,李建凤,王兵,古小松,洪小苏.尿微量白蛋白和胰岛素抵抗在非糖尿病患者冠心病发病中的作用[J].江苏医药,2013,39(2):194-196. 被引量:8
  • 10曾龙驿.肥胖与胰岛素抵抗[J].中华医学杂志,2012,92(30):2091-2092. 被引量:15

二级参考文献34

  • 1Chen CM. Eating patterns--a prognosis for China. Asia Pac J Clin Nutr, 1995,4 Suppl 1:24-28.
  • 2Wang Y, Mi J, Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) , 2007,31:177-188.
  • 3Barth RJ. Insulin resistance, obesity and the metabolic syndrome. S D Med, 2011 ,Spec No:22-27.
  • 4Pou KM, Massaro JM, Hoffmann U, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care, 2009,32:481-485.
  • 5Tran TT, Yamamoto Y, Gesta S, et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab, 2008,7:410-420.
  • 6Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab, 2002, 87: 2784-2791.
  • 7Kim SH, Reaven G. Obesity and insulin resistance: an ongoing saga. Diabetes, 2010,59:2105-2106.
  • 8Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol, 2007,2: 31-56.
  • 9Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest, 1998, 101: 1354-1361.
  • 10Nystrom FH, Chen H, Cong LN, et al. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocfinol, 1999,13:2013-2024.

共引文献32

同被引文献85

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 2李志刚,马康华.肿瘤坏死因子-α对脂肪细胞中脂联素表达的影响[J].临床心血管病杂志,2007,23(5):361-364. 被引量:19
  • 3Kumar KG, Trevaskis JL,Daniel DL, et al. Stephens and andrew a. butler, identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolisml-J~. Cell Metab, 2008,8 (6) ..468-481.
  • 4Kumar KG, Zhang JY, Gao S, et al. Adropin deficiency is associated with increased adiposity and insulin resistance [J]. Obesity, 2012,20(7) : 1394-1402.
  • 5Lovren F,Pan Y,Quan A,et al. Adropin is a novel regula- tor of endothelial function[J]. Circulation, 2010,122 (Sup- pl 11) :185-192.
  • 6Kuloglu T,Aydin S. Immunohistochemical expressions of adropin and nducible nitric oxide synthase in renal tissues of rats with streptozotocin-1 nduced experimental diabetes [J]. Biotech Histochem, 2014,89 (2) .. 104-110.
  • 7Jones E, Eteiba W, Merz NB. Cardiac syndrome X and mi- crovascular coronary dysfunction[J]. Trends Cardiovasc Med,2012,22 (6) :161-168.
  • 8Celik A,Balin M,Kobat MA,et al. Deficiency of a new pro- tein associated with cardiac syndrome X; called adropin[J]. Cardiovasc Ther,2013,31(3) :174-178.
  • 9Celik A, Yilmaz E, Celik O, et al. Maternal and fetal adropin levels in gestational diabetes mellitus[J]. J Peri- nat Med,2013,41(4) :375-380.
  • 10Nosaka K, Nakamura K, Kusano K, et al. Serum cystatin C as a biomarker of cardiac diastolic dysfunction in pa- tients with cardiac disease and preserved ejection fraction [J]. Congest Heart Fail,2013,19(4) :35-39.

引证文献13

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部